• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超分辨率显微镜兼容的荧光探针揭示内源性胰高血糖素样肽-1 受体的分布和动态。

Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics.

机构信息

Institute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, UK.

Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK.

出版信息

Nat Commun. 2020 Jan 24;11(1):467. doi: 10.1038/s41467-020-14309-w.

DOI:10.1038/s41467-020-14309-w
PMID:31980626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6981144/
Abstract

The glucagon-like peptide-1 receptor (GLP1R) is a class B G protein-coupled receptor (GPCR) involved in metabolism. Presently, its visualization is limited to genetic manipulation, antibody detection or the use of probes that stimulate receptor activation. Herein, we present LUXendin645, a far-red fluorescent GLP1R antagonistic peptide label. LUXendin645 produces intense and specific membrane labeling throughout live and fixed tissue. GLP1R signaling can additionally be evoked when the receptor is allosterically modulated in the presence of LUXendin645. Using LUXendin645 and LUXendin651, we describe islet, brain and hESC-derived β-like cell GLP1R expression patterns, reveal higher-order GLP1R organization including membrane nanodomains, and track single receptor subpopulations. We furthermore show that the LUXendin backbone can be optimized for intravital two-photon imaging by installing a red fluorophore. Thus, our super-resolution compatible labeling probes allow visualization of endogenous GLP1R, and provide insight into class B GPCR distribution and dynamics both in vitro and in vivo.

摘要

胰高血糖素样肽-1 受体(GLP1R)是一种 B 类 G 蛋白偶联受体(GPCR),参与代谢。目前,其可视化仅限于遗传操作、抗体检测或使用刺激受体激活的探针。在此,我们提出了 LUXendin645,一种远红色荧光 GLP1R 拮抗肽标签。LUXendin645 在活组织和固定组织中产生强烈且特异性的膜标记。当受体在 LUXendin645 存在下被变构调节时,还可以引发 GLP1R 信号。使用 LUXendin645 和 LUXendin651,我们描述了胰岛、大脑和 hESC 衍生的β样细胞 GLP1R 的表达模式,揭示了包括膜纳米域在内的更高阶 GLP1R 组织,并且可以跟踪单个受体亚群。此外,我们还表明,可以通过安装红色荧光团来优化 LUXendin 骨架,以用于活体双光子成像。因此,我们的超分辨率兼容标记探针允许可视化内源性 GLP1R,并提供对 B 类 GPCR 分布和动力学的深入了解,无论是在体外还是体内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/b8e58937d7e5/41467_2020_14309_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/f69677d7243f/41467_2020_14309_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/d0dc3d40de9c/41467_2020_14309_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/bd9b2949e332/41467_2020_14309_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/ed0c8f3a6def/41467_2020_14309_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/b8f658bfdd4d/41467_2020_14309_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/7070e8ea43ff/41467_2020_14309_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/1df2e7849e38/41467_2020_14309_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/4e42e7c72340/41467_2020_14309_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/b8e58937d7e5/41467_2020_14309_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/f69677d7243f/41467_2020_14309_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/d0dc3d40de9c/41467_2020_14309_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/bd9b2949e332/41467_2020_14309_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/ed0c8f3a6def/41467_2020_14309_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/b8f658bfdd4d/41467_2020_14309_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/7070e8ea43ff/41467_2020_14309_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/1df2e7849e38/41467_2020_14309_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/4e42e7c72340/41467_2020_14309_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d63/6981144/b8e58937d7e5/41467_2020_14309_Fig9_HTML.jpg

相似文献

1
Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics.超分辨率显微镜兼容的荧光探针揭示内源性胰高血糖素样肽-1 受体的分布和动态。
Nat Commun. 2020 Jan 24;11(1):467. doi: 10.1038/s41467-020-14309-w.
2
Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling.揭示内源性胰高血糖素样肽-1 受体表达和信号转导的组织水平复杂性。
Nat Commun. 2023 Jan 18;14(1):301. doi: 10.1038/s41467-022-35716-1.
3
Development and characterisation of a novel glucagon like peptide-1 receptor antibody.新型胰高血糖素样肽-1 受体抗体的研发与特性分析。
Diabetologia. 2018 Mar;61(3):711-721. doi: 10.1007/s00125-017-4491-0. Epub 2017 Nov 9.
4
Expanded LUXendin Color Palette for GLP1R Detection and Visualization In Vitro and In Vivo.用于体外和体内GLP1R检测与可视化的扩展LUXendin调色板
JACS Au. 2022 Apr 4;2(4):1007-1017. doi: 10.1021/jacsau.2c00130. eCollection 2022 Apr 25.
5
miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.miR-204 调控胰高血糖素样肽 1 受体表达和激动剂功能。
Diabetes. 2018 Feb;67(2):256-264. doi: 10.2337/db17-0506. Epub 2017 Nov 3.
6
Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1.胰高血糖素样肽-1(GLP-1)主链修饰诱导的GLP-1受体信号偏差的表征
Biochem Pharmacol. 2017 Jul 15;136:99-108. doi: 10.1016/j.bcp.2017.03.018. Epub 2017 Mar 29.
7
A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus.下丘脑胰高血糖素样肽-1 受体和葡萄糖依赖性胰岛素释放多肽受体表达细胞的比较转录组学分析。
Appetite. 2022 Jul 1;174:106022. doi: 10.1016/j.appet.2022.106022. Epub 2022 Apr 14.
8
GLP-1 Receptor Expression Within the Human Heart.GLP-1 受体在人心脏中的表达。
Endocrinology. 2018 Apr 1;159(4):1570-1584. doi: 10.1210/en.2018-00004.
9
Reagents and models for detecting endogenous GLP1R and GIPR.检测内源性 GLP1R 和 GIPR 的试剂和模型。
EBioMedicine. 2021 Dec;74:103739. doi: 10.1016/j.ebiom.2021.103739. Epub 2021 Dec 12.
10
Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonists.从进化上古老的鱼类中分离得到的胰高血糖素样肽-1 作为双重 GLP1R 和 GCGR 激动剂,具有很强的抗糖尿病活性。
Mol Cell Endocrinol. 2019 Jan 15;480:54-64. doi: 10.1016/j.mce.2018.10.011. Epub 2018 Oct 9.

引用本文的文献

1
Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists.关于胰高血糖素样肽-1(GLP-1)和GLP-1受体激动剂进入大脑的当前认识与争议
J Transl Int Med. 2025 Jun 20;13(3):201-210. doi: 10.1515/jtim-2025-0026. eCollection 2025 Jun.
2
Lighting up targets of dual agonist therapies for diabetes and obesity.点亮糖尿病和肥胖症双重激动剂疗法的靶点。
Nat Metab. 2025 Aug;7(8):1507-1508. doi: 10.1038/s42255-025-01346-2.
3
Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain.

本文引用的文献

1
Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells.激动剂诱导的膜纳米域聚类驱动胰腺β细胞中的 GLP-1 受体反应。
PLoS Biol. 2019 Aug 20;17(8):e3000097. doi: 10.1371/journal.pbio.3000097. eCollection 2019 Aug.
2
Function and mechanisms of enteroendocrine cells and gut hormones in metabolism.肠内分泌细胞和肠道激素在代谢中的功能和机制。
Nat Rev Endocrinol. 2019 Apr;15(4):226-237. doi: 10.1038/s41574-019-0168-8.
3
Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cells.
荧光GLP1R/GIPR双激动剂探针揭示胰腺和大脑中的细胞靶点。
Nat Metab. 2025 Aug 19. doi: 10.1038/s42255-025-01342-6.
4
Cardiovascular and brain effects of liraglutide in transthyretin amyloidosis (ATTR) mice models.利拉鲁肽在转甲状腺素蛋白淀粉样变性(ATTR)小鼠模型中的心血管和脑效应。
Int J Med Sci. 2025 Jul 10;22(13):3229-3241. doi: 10.7150/ijms.112264. eCollection 2025.
5
SNAPpa: A Photoactivatable SNAP-tag for the Spatiotemporal Control of Protein Labeling.SNAPpa:一种用于蛋白质标记时空控制的光激活SNAP标签。
JACS Au. 2025 Jul 17;5(7):3589-3602. doi: 10.1021/jacsau.5c00603. eCollection 2025 Jul 28.
6
Downstream interaction by glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonism is required for synergistic effects on body weight.胰高血糖素样肽-1和葡萄糖依赖性促胰岛素多肽激动剂的下游相互作用是对体重产生协同作用所必需的。
Mol Metab. 2025 Sep;99:102214. doi: 10.1016/j.molmet.2025.102214. Epub 2025 Jul 16.
7
Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communication.局部GLP1受体预内化引导胰腺α细胞与β细胞通讯。
Cell Metab. 2025 Jul 7. doi: 10.1016/j.cmet.2025.06.009.
8
Endogenous SNAP-Tagging of Munc13‑1 for Monitoring Synapse Nanoarchitecture.用于监测突触纳米结构的Munc13-1内源性SNAP标记
JACS Au. 2025 May 23;5(6):2475-2490. doi: 10.1021/jacsau.4c00946. eCollection 2025 Jun 23.
9
Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer's Disease.抗糖尿病胰高血糖素样肽-1受体激动剂在阿尔茨海默病实验动物模型中具有神经保护特性。
Pharmaceuticals (Basel). 2025 Apr 23;18(5):614. doi: 10.3390/ph18050614.
10
Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.胰高血糖素样肽-1与下丘脑对饱腹感的调节:来自人类和动物研究的认知与神经学见解
Diabetes Metab J. 2025 May;49(3):333-347. doi: 10.4093/dmj.2025.0106. Epub 2025 May 1.
在培养中重现内分泌细胞的簇集促进了人干细胞衍生的β细胞的成熟。
Nat Cell Biol. 2019 Feb;21(2):263-274. doi: 10.1038/s41556-018-0271-4. Epub 2019 Feb 1.
4
GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P/Q-type Ca channels.胰高血糖素样肽-1通过抑制P/Q型钙通道来抑制人胰腺α细胞中的胰高血糖素分泌。
Physiol Rep. 2018 Sep;6(17):e13852. doi: 10.14814/phy2.13852.
5
Mice harboring the human R138X loss-of-function mutation have increased insulin secretory capacity.携带人类 R138X 无功能突变的小鼠具有增加的胰岛素分泌能力。
Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):E7642-E7649. doi: 10.1073/pnas.1721418115. Epub 2018 Jul 23.
6
A New Fluorogenic Small-Molecule Labeling Tool for Surface Diffusion Analysis and Advanced Fluorescence Imaging of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Based on Silicone Rhodamine: SiR-BACE1.一种用于表面扩散分析和基于硅罗丹明的β-淀粉样前体蛋白裂解酶 1 的荧光成像的新型荧光小分子标记工具:SiR-BACE1。
J Med Chem. 2018 Jul 26;61(14):6121-6139. doi: 10.1021/acs.jmedchem.8b00387. Epub 2018 Jul 10.
7
Conditional and Reversible Activation of Class A and B G Protein-Coupled Receptors Using Tethered Pharmacology.利用拴系药理学对A类和B类G蛋白偶联受体进行条件性和可逆性激活
ACS Cent Sci. 2018 Feb 28;4(2):166-179. doi: 10.1021/acscentsci.7b00237. Epub 2018 Jan 16.
8
Single-molecule imaging reveals receptor-G protein interactions at cell surface hot spots.单分子成像揭示细胞表面热点处的受体- G 蛋白相互作用。
Nature. 2017 Oct 26;550(7677):543-547. doi: 10.1038/nature24264. Epub 2017 Oct 18.
9
A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus.胰高血糖素样肽-1 受体激动剂可降低脑积水大鼠模型的颅内压。
Sci Transl Med. 2017 Aug 23;9(404). doi: 10.1126/scitranslmed.aan0972.
10
Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.氨基酸转运蛋白Slc38a5控制胰高血糖素受体抑制诱导的小鼠胰腺α细胞增生。
Cell Metab. 2017 Jun 6;25(6):1348-1361.e8. doi: 10.1016/j.cmet.2017.05.006.